Literature DB >> 22198913

Cytomegalovirus: recent progress in understanding pathogenesis and control.

V C Emery1.   

Abstract

Cytomegalovirus continues to be an important pathogen in a variety of patient groups especially the neonate and the transplant recipient, and has implicated in a range of pathologies including inflammatory disease and in contributing to early death in ageing populations. This review will focus on advances in understanding the virus-host interaction and options for the new therapeutic control measures.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22198913      PMCID： PMC3328974          DOI： 10.1093/qjmed/hcr262

Source DB:  PubMed          Journal:  QJM        ISSN： 1460-2393


  25 in total

1.  Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation.

Authors:  V C Emery; C A Sabin; A V Cope; D Gor; A F Hassan-Walker; P D Griffiths
Journal:  Lancet       Date:  2000-06-10       Impact factor: 79.321

2.  Modelling cytomegalovirus replication patterns in the human host: factors important for pathogenesis.

Authors:  Roland R Regoes; E Frances Bowen; Alethea V Cope; Dehila Gor; Aycan F Hassan-Walker; H Grant Prentice; Margaret A Johnson; Paul Sweny; Andrew K Burroughs; Paul D Griffiths; Sebastian Bonhoeffer; Vincent C Emery
Journal:  Proc Biol Sci       Date:  2006-08-07       Impact factor: 5.349

3.  Safety and immunogenicity of a bivalent cytomegalovirus DNA vaccine in healthy adult subjects.

Authors:  Mary K Wloch; Larry R Smith; Souphaphone Boutsaboualoy; Luane Reyes; Christina Han; Jackie Kehler; Heather D Smith; Linda Selk; Ryotaro Nakamura; Janice M Brown; Thomas Marbury; Anna Wald; Alain Rolland; David Kaslow; Thomas Evans; Michael Boeckh
Journal:  J Infect Dis       Date:  2008-06-15       Impact factor: 5.226

4.  PD-1 expression and IL-2 loss of cytomegalovirus- specific T cells correlates with viremia and reversible functional anergy.

Authors:  U Sester; D Presser; J Dirks; B C Gärtner; H Köhler; M Sester
Journal:  Am J Transplant       Date:  2008-07       Impact factor: 8.086

5.  Inflammation in common variable immunodeficiency is associated with a distinct CD8(+) response to cytomegalovirus.

Authors:  Sayed Mahdi Marashi; Mohammad Raeiszadeh; Sarita Workman; Afsar Rahbar; Cecilia Soderberg-Naucler; Paul Klenerman; Ronnie Chee; A David Webster; Richard S B Milne; Vincent C Emery
Journal:  J Allergy Clin Immunol       Date:  2011-05-04       Impact factor: 10.793

Review 6.  Human cytomegalovirus persists in its host and attacks and avoids elimination by the immune system.

Authors:  Cecilia Soderberg-Naucler
Journal:  Crit Rev Immunol       Date:  2006       Impact factor: 2.214

7.  Polyfunctional cytomegalovirus-specific CD4+ and pp65 CD8+ T cells protect against high-level replication after liver transplantation.

Authors:  G Nebbia; F M Mattes; C Smith; E Hainsworth; J Kopycinski; A Burroughs; P D Griffiths; P Klenerman; V C Emery
Journal:  Am J Transplant       Date:  2008-10-06       Impact factor: 8.086

8.  Shift of CMV-specific CD4+ T-cells to the highly differentiated CD45RO-CD27- phenotype parallels loss of proliferative capacity and precedes progression to HIV-related CMV end-organ disease.

Authors:  Corine Bronke; Christine A Jansen; Geertje H A Westerlaken; Iris M De Cuyper; Frank Miedema; Kiki Tesselaar; Debbie van Baarle
Journal:  Clin Immunol       Date:  2007-06-06       Impact factor: 3.969

9.  Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection.

Authors:  Daniele Lilleri; Chiara Fornara; Antonella Chiesa; Daniela Caldera; Emilio Paolo Alessandrino; Giuseppe Gerna
Journal:  Haematologica       Date:  2008-02       Impact factor: 9.941

10.  Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects.

Authors:  Andrew W Sylwester; Bridget L Mitchell; John B Edgar; Cara Taormina; Christian Pelte; Franziska Ruchti; Paul R Sleath; Kenneth H Grabstein; Nancy A Hosken; Florian Kern; Jay A Nelson; Louis J Picker
Journal:  J Exp Med       Date:  2005-09-05       Impact factor: 14.307
View more
  7 in total

1.  The 6-Aminoquinolone WC5 inhibits different functions of the immediate-early 2 (IE2) protein of human cytomegalovirus that are essential for viral replication.

Authors:  Beatrice Mercorelli; Anna Luganini; Giulia Muratore; Serena Massari; Maria Elena Terlizzi; Oriana Tabarrini; Giorgio Gribaudo; Giorgio Palù; Arianna Loregian
Journal:  Antimicrob Agents Chemother       Date:  2014-08-25       Impact factor: 5.191

2.  Characteristics and influencing factors of CD19+ B cell reconstitution in patients following haploidentical/mismatched hematopoietic stem cell transplantation.

Authors:  Min Xie; Hai-Xia Fu; Ying-Jun Chang; Lan-Ping Xu; Dai-Hong Liu; Xiao-Hui Zhang; Wei Han; Kai-Yan Liu; Xiao-Jun Huang
Journal:  Int J Hematol       Date:  2012-06-07       Impact factor: 2.490

Review 3.  In-depth summary over cytomegalovirus infection in allogeneic hematopoietic stem cell transplantation recipients.

Authors:  Samira Karami; Elham Roshandel; Haniyeh Ghaffari Nazari; Abbas Hajifathali; Farzaneh Tavakoli; Sayeh Parkhideh
Journal:  Virusdisease       Date:  2021-07-28

Review 4.  Functional genomics approaches to understand cytomegalovirus replication, latency and pathogenesis.

Authors:  Igor Landais; Jay A Nelson
Journal:  Curr Opin Virol       Date:  2013-06-29       Impact factor: 7.090

5.  Virucidal action of sore throat lozenges against respiratory viruses parainfluenza type 3 and cytomegalovirus.

Authors:  Adrian Shephard; Stela Zybeshari
Journal:  Antiviral Res       Date:  2015-09-25       Impact factor: 5.970

6.  MicroRNA‑1929‑3p participates in murine cytomegalovirus‑induced hypertensive vascular remodeling through Ednra/NLRP3 inflammasome activation.

Authors:  Wei Zhou; Dongmei Xi; Yunzhong Shi; Lamei Wang; Hua Zhong; Zhen Huang; Yongmin Liu; Yan Tang; Ning Lu; Yongjia Wang; Zhengyu Zhang; Jiaxin Pei; Na Tang; Fang He
Journal:  Int J Mol Med       Date:  2020-12-22       Impact factor: 4.101

7.  Cytomegalovirus infection and disease reduce 10-year cardiac allograft vasculopathy-free survival in heart transplant recipients.

Authors:  Inger Johansson; Rune Andersson; Vanda Friman; Nedim Selimovic; Lars Hanzen; Salmir Nasic; Ulla Nyström; Vilborg Sigurdardottir
Journal:  BMC Infect Dis       Date:  2015-12-24       Impact factor: 3.090
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.